10.24.22

Expanding Presbyopia Treatment Options

Y. Ralph Chu, MD, welcomes Selina McGee, OD, FAAO, to discuss how the evaluation of presbyopia treatment options allows for more customized therapy for patients. The two explain how the presbyopia treatment landscape has evolved in recent years and how they talk to patients about all therapeutic options, including the recently FDA-approved Vuity (pilocarpine HCl ophthalmic solution 1.25%, Allergan). Dr. McGee says that, with several different therapeutic options, she can tailor treatment based on a comprehensive eye examination and consultation about a patient’s lifestyle goals.

View full description +

MORE EPISODES

10.24.22

Expanding Presbyopia Treatment Options

Y. Ralph Chu, MD; and Selina McGee, OD, FAAO

07.27.22

Expanding Treatment Options for Presbyopia

William B. Trattler, MD; Cecelia Koetting, OD, FAAO; and Justin Schweitzer, OD, FAAO

04.13.22

A Paradigm Shift in Presbyopia Management

Cathleen M. McCabe, MD; Daniel H. Chang, MD; and Rachael Wruble, OD, FAAO

01.26.22

Discussing Presbyopia Solutions With Patients

George O. Waring IV, MD, FACS; Walter O. Whitley, OD, MBA, FAAO; and Marc R. Bloomenstein, OD, FAAO

10.25.21

Patient Communication

Laura M. Periman, MD ; Mitchell Jackson, MD; Cecelia Koetting, OD; Justin Schweitzer, OD

08.19.21

The In-Between Patients

David A. Goldman, MD, Selina McGee, OD, FAAO, David Geffen, OD

04.01.21

Time for Change: Classifying Presbyopia Simply

Marguerite McDonald, MD; Leslie O’Dell, OD; Rachael A. Wruble, OD; and William B. Trattler, MD

02.12.21

Changing the Landscape of Presbyopia

Jonathan Solomon, MD; Melissa Barnett, OD, FAAO, FSLS, FBCLA; Roberto “Bobby” Saenz, OD, MS, FAAO; and Neda Shamie, MD